Possible neuroprotective effect of withania somnifera root extract against 3-Nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of huntington's disease

Journal of Medicinal Food

Volumn 12, Issue 3, 2009, Pages 591-600

  Kumar, Puneet ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

3 nitropropionic acid; Huntington's disease; Oxidative stress; Withania somnifera

Indexed keywords

3 NITROPROPIONIC ACID; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; WITHANIA SOMNIFERA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; GAIT DISORDER; HUNTINGTON CHOREA; MALE; NERVE DEGENERATION; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PLANT ROOT; PRIORITY JOURNAL; RAT; WITHANIA SOMNIFERA;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; CATALASE; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; MITOCHONDRIA; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRO COMPOUNDS; OXIDOREDUCTASES; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PROPIONIC ACIDS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; WITHANIA;

ANIMALIA; RATTUS; WITHANIA SOMNIFERA;

EID: 68149136975     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0028     Document Type: Article

References (60)

1. Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz JB: 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J Neurochem 1995;65:919-922.
2. Borlongan CV, Koutouzis TK, Sanberg PR: 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 1997;21:289-293.
3. Butterfield DA, Howard BJ, LaFontaine MA: Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Hunting- ton's disease. Curr Med Chem 2001;8:815-818.
4. Beal MF: Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-223.
5. Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F, Palfi S, Hantraye P: Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 1998;70:794-805.
6. Kumar P, Padi SS, Naidu PS, Kumar A: Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 2006;17:485-492.
7. Schulz JB, Henshaw DR, MacGarvey U, Beal MF: Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neu- rochem Int 1996;29:167-171.
8. Cakala M, Drabik J, Kaźmierczak A, Kopczuk D, Adamczyk A: Inhibition of mitochondrial complex II affects dopamine metabolism and decreases its uptake into striatal synaptosomes. Folia Neuropathol 2006;44 238-243.
9. Herrera-Mundo MN, Silva-Adaya D, Maldonado PD, Galván- Arzate S, Andrés-Martínez L, Pérez-De La Cruz V, Pedraza- Chaverrf J, Santamaria A: S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxi- dative stress and mitochondrial dysfunction. Neurosci Res 2006; 56:39-44.
10. Perez-De La Cruz V, González-Cortés C, Pedraza- Chaverŕi J, Maldonado PD, Andrés-Martínez L, Santamaría A: Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synap- tosomes. Brain Res Bull 2006;68:379-383.
11. Kumar P, Padi SS, Naidu PS, Kumar A: Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid- induced neurotoxicity. Methods Findings Exp Clin Pharmacol 2007;29:1-7.
12. Bonelli RM, Hofmann P: A review of the treatment options for Huntington's disease. Expert Opin Pharmacother 2004;5:767-776.
13. Tunez I, Feijóo M, Collado JA, Medina FJ, Peña J, Muñoz Mdel C, Jimena I, Franco F, Rueda I, Muntané J, Montilla P: Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats. Life Sci 2007;80:1221-1227.
14. Túnez I, Montilla P, Muñoz MC, Drucker-Colin R: Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in syn- aptosomes. Eur J Pharmacol 2004;504:169-175.
15. Kim GW, Chan PH: Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mito- chondrial toxin 3-nitropropionic acid in the mouse striatum. Neurobiol Dis 2001;8:114-1126.
16. Ali M, Shuaib M: Withanolides from the stem bark of Withania somnifera. Photochemistry 1997;44:1163-1168.
17. Kulkarni SK, Dhir A: Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1093-1105.
18. Bhattacharya SK, Bhattacharya D, Sairam K, Ghosal S: Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia. Phytomedicine 2002;9:167-170.
19. Naidu PS, Singh A, Kulkarni SK: Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res 2006;20:140-146.
20. Parihar MS, Hemnani T: Phenolic antioxidants attenuate hippo- campal neuronal cell damage against kainic acid induced ex-citotoxicity. J Biosci 2003;28:121-128.
21. Misra L, Mishra P, Pandey A, Sangwan RS, Sangwan NS, Tuli R: Withanolides from Withania somnifera roots. Phytochemistry 2008;69:1000-1004.
22. Kulkarni SK, Verma A: Ashwagandha and Bramhi: nootropic and de-addiction profile of psychotropic indigenous plants. Drugs Today 1993;29:257-263.
23. Naidu PS, Singh A, Kulkarni SK: Effect of Withania som- nifera root extract on haloperidol-induced orofacial dyski- nesia: possible mechanisms of action. J Med Food 2003;6: 107-114.
24. Reddy DS, Kulkarni SK: Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizociline induced leaning impairment. Brain Res 1998;799:215-219.
25. rd ed. Vallabh Parkashan, New Delhi, 1999.
26. Tariq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K: Neu- roprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res Bull 2005;67:161-168.
27. Vis JC, Verbeek MM, De Waal RMW, Ten Donkelaar HJ, Krener HPH: 3-Nitropropionic acid induces a spectrum of Huntington's disease like neuropathology in rat striatum. Neu-ropathol Appl Neurobiol 1999;25:513-521.
28. Wills ED: Mechanism of lipid peroxide formation in animal. Biochem J 1966;99:667-676.
29. 15N] nitrate in biological fluids. Ann Biochem 1982;126:131-138.
30. Luck H: Catalase. In: Methods of Enzymatic Analysis (Berg- meyer HU, ed.). Academic Press, New York, 1971, pp. 885-893.
31. Kono Y: Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem Biophys 1978;186:189-195.
32. King J: Colorimetric estimation of lactate dehydrogenase. J Med Lab Tech 1959;16:256-261.
33. Gornall AG, Bardawill CJ, David MM: Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177: 751-766.
34. Berman SB, Hastings TG: Dopamine oxidation alters mito- chondrial respiration and induces permeability transition in brain: implication for Parkinson's disease. J Neurochem 1999;73:1127- 1137.
35. Clark JB, Bates TE, Boakye P, Kuimov A, Land JM: Investigation of mitochondrial defects in brain and skeletal muscle. In: Neurochemistry: A Practical Approach (Turner AJ, Bache- lard HS, eds.). Oxford University Press, New York, 1997, pp. 151-174.
36. Kumar P, Padi SS, Naidu PS, Kumar A: Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms. Fundam Clin Pharmacol 2007;21:297-306.
37. McCurrach ME, Lowe SW: Methods for studying pro- and an- tiapoptotic genes in nonimmortal cells. Methods Cell Biol 2001; 66:197-227.
38. Browne SE, Ferrante RJ, Beal MF: Oxidative stress in Hun- tington's disease. Brain Pathol 1999;9:147-163.
39. Montilla P, Tunez I, Munoz MC, Salcedo M, Feijoo M, Munoz- Castaneda JR, Bujalance I: Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. Eur J Pharmacol 2004;488:19-25.
40. Túnez I, Moñtilla P, del Carmen Munoz M, Medina FJ, Drucker- Colfn R: Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes. Neurosci Res 2006;56:91-95.
41. Patocka J, Bielavsky J, Cabal J, Fusek J: 3-Nitropropionic acid and similar nitrotoxins. Acta Medica (Hradec Kralove) 2000;43: 9-13.
42. Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW: Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res 2003;994:44-54.
43. Grandhi A, Mujumdar AM, Patwardhan B: A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethanopharmacol 1994;44:131-135.
44. Dhuley JN: Adaptogenic and cardioprotective action of ashwa- gandha in rats and frogs. J Ethnopharmacol 2000;70:57-63.
45. Winston D, Maimes S: Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Healing Arts Press, Rochester, VT, 2007.
46. Puri HS: RASAYANA: Ayurvedic Herbs of Rejuvenation and Longevity. Taylor & Francis, London, 2003, pp. 46-58.
47. Chaudhary G, Sharma U, Jagannathan NR, Gupta YK: Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 2003;30: 399-404.
48. Bhattacharya A, Ghosal S, Bhattacharya SK: Anti-oxidant effect of Withania somnifera glycowithanolides in chronic foot shock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 2001;74:1-6.
49. Schulz JB, Matthews RT, Henshaw DR, Beal MF: Neuropro-tective strategies for treatment of lesions produced by mito- chondrial toxins: implications for neurodegenerative diseases. Neuroscience 1996;71:1043-1048.
50. Tunez I, Montilla P, Del Carmen Munoz M, Feijoo M, Salcedo M: Protective effect of melatonin on 3-nitropropionic acid- induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J Pineal Res 2004;37:252-256.
51. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D: Stabilization of membrane bound enzyme profiles and lipid per- oxidation by Withania somnifera along with paclitaxel on ben- zo(a)pyrene induced experimental lung cancer. Mol Cell Biochem 2006;292:13-17.
52. Bhattacharya SK, Goel RK, Kaur R, Ghosal S: Antistress activity of sinoidosides VII and VIII. New acylsterylglycosides from W. somnifera. Phytother Res 1987;1:32-37.
53. Sankar SR, Manivasagam T, Krishnamurti A, Ramanathan M: The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett 2007;12:473-481.
54. Reynolds IJ, Hastings TG: Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 1995;15:3318-3327.
55. Kaur P, Sharma M, Mathur S, Tiwari M, Divekar HM, Kumar R, Srivastava KK, Chandra R: Effect of 1-oxo-5beta, 6beta-epoxy- witha-2-ene-27-ethoxy-olide isolated from the roots of Withania somnifera on stress indices in Wistar rats. J Altern Complement Med 2003;9:897-907.
56. Huang LS, Sun G, Cobessei D, Wang A, Shan JT, Tung EY, Anderson VE, Berry EA: 3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex-II, forms a covalent adduct with a catalytic-base argi- nine in the active site of the enzyme. J Biol Chem 2006;281: 5965-5972.
57. Begum VH, Sadique J: Effect of Withania somnifera on gly- cosaminoglycan synthesis in carrageenin-induced air pouch granuloma. Biochem Med Metab Biol 1987;38:272-277.
58. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D: Modulation of TCA cycle enzymes and electron transport chain systems in experimental lung cancer. Life Sci 2006;78:1010-1014.
59. Kulkarni SK, Sharma A, Verma A, Ticku MK: GABA receptor mediated anticonvulsant action of Withania somnifera root extract. Indian Drugs 1993;30:305-312.
60. Dhuley JN: Effect of Ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol 1998;60:173-178.